Form 4: Allovir CEO Diana Brainard Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Allovir's CEO, Diana Brainard, sold shares to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On May 17, 2024, Diana Brainard, CEO of Allovir, Inc., sold 3,075 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $0.7493, with individual transactions ranging from $0.74 to $0.7615.
- Following the transaction, Brainard directly owns 789,620 shares of Allovir common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (selling shares to cover taxes), so the sentiment is neutral.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder sentiment, although it is a common practice.
Key Dates
| Date | Description |
|---|---|
| 05/17/2024 | Date of stock sale transaction |
| 05/21/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.